Literature DB >> 23073146

Role of the systemic immune system in brain metastasis.

Alastair Hamilton1, Nicola R Sibson.   

Abstract

Metastatic disease in the central nervous system (CNS) is a cause of increasing mortality amongst cancer patients. As with other types of cancer, cells of the systemic immune system play a range of important roles in the development of metastatic lesions in the CNS, both repressing and promoting tumour growth. Recent advances in immunotherapy have changed the emphasis in cancer treatment away from conventional chemotherapy and radiotherapy for certain tumour types. Despite this, our understanding of systemic immune system involvement in CNS metastases remains poor. The blood-brain barrier prevents the majority of diagnostic and therapeutic agents from crossing into the brain parenchyma until the late stages of metastatic disease. Thus, the development of immunotherapy for CNS pathologies is particularly desirable. This review draws together our current understanding in the relationships between CNS metastases and circulating systemic immune cells. We discuss the roles that circulating systemic immune cells may play in the homing of metastatic cells to the perivascular space, and the pro-metastatic and antagonistic roles that infiltrating systemic immune cells may play at sites of metastasis. This article is part of a Special Issue entitled 'Neuroinflammation in neurodegeneration and neurodysfunction'.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23073146     DOI: 10.1016/j.mcn.2012.10.004

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  25 in total

1.  Local failure after stereotactic radiosurgery (SRS) for intracranial metastasis: analysis from a cooperative, prospective national registry.

Authors:  Anthony L Asher; Mohammed Ali Alvi; Mohamad Bydon; Nader Pouratian; Ronald E Warnick; James McInerney; Inga S Grills; Jason Sheehan
Journal:  J Neurooncol       Date:  2021-01-22       Impact factor: 4.130

Review 2.  Brain metastasis: new opportunities to tackle therapeutic resistance.

Authors:  Joan Seoane; Leticia De Mattos-Arruda
Journal:  Mol Oncol       Date:  2014-06-02       Impact factor: 6.603

Review 3.  Embracing rejection: Immunologic trends in brain metastasis.

Authors:  S Harrison Farber; Vadim Tsvankin; Jessica L Narloch; Grace J Kim; April K S Salama; Gordana Vlahovic; Kimberly L Blackwell; John P Kirkpatrick; Peter E Fecci
Journal:  Oncoimmunology       Date:  2016-04-11       Impact factor: 8.110

Review 4.  Foe or friend? Janus-faces of the neurovascular unit in the formation of brain metastases.

Authors:  Imola Wilhelm; Csilla Fazakas; Kinga Molnár; Attila G Végh; János Haskó; István A Krizbai
Journal:  J Cereb Blood Flow Metab       Date:  2017-09-18       Impact factor: 6.200

Review 5.  Immune Checkpoint Inhibitors for Brain Metastases.

Authors:  Aaron C Tan; Amy B Heimberger; Alexander M Menzies; Nick Pavlakis; Mustafa Khasraw
Journal:  Curr Oncol Rep       Date:  2017-06       Impact factor: 5.075

Review 6.  Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases.

Authors:  Kirtesh R Patel; David H Lawson; Ragini R Kudchadkar; Bradley C Carthon; Daniel E Oliver; Derick Okwan-Duodu; Rafi Ahmed; Mohammad K Khan
Journal:  Neuro Oncol       Date:  2015-05-25       Impact factor: 12.300

Review 7.  An integrative view on sex differences in brain tumors.

Authors:  Tao Sun; Anya Plutynski; Stacey Ward; Joshua B Rubin
Journal:  Cell Mol Life Sci       Date:  2015-05-19       Impact factor: 9.261

8.  Integrated genomic and epigenomic analysis of breast cancer brain metastasis.

Authors:  Bodour Salhia; Jeff Kiefer; Julianna T D Ross; Raghu Metapally; Rae Anne Martinez; Kyle N Johnson; Danielle M DiPerna; Kimberly M Paquette; Sungwon Jung; Sara Nasser; Garrick Wallstrom; Waibhav Tembe; Angela Baker; John Carpten; Jim Resau; Timothy Ryken; Zita Sibenaller; Emanuel F Petricoin; Lance A Liotta; Ramesh K Ramanathan; Michael E Berens; Nhan L Tran
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

9.  Identification of brain metastasis genes and therapeutic evaluation of histone deacetylase inhibitors in a clinically relevant model of breast cancer brain metastasis.

Authors:  Soo-Hyun Kim; Richard P Redvers; Lap Hing Chi; Xiawei Ling; Andrew J Lucke; Robert C Reid; David P Fairlie; Ana Carolina Baptista Moreno Martin; Robin L Anderson; Delphine Denoyer; Normand Pouliot
Journal:  Dis Model Mech       Date:  2018-07-06       Impact factor: 5.758

10.  Expression and Prognostic Value of ARID5A and its Correlation With Tumor-Infiltrating Immune Cells in Glioma.

Authors:  Quan Zhou; Jinping Zhou; Jingyi Fan
Journal:  Front Oncol       Date:  2021-05-19       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.